Abbott dives into cancer diagnostics with $23B buyout of Exact Sciences
Abbott has signed up to buy Exact Sciences in the largest diagnostics deal to date, acquiring the maker of the Cologuard at-home screening test for colorectal cancer and new blood-based tests for multiple tumors.
Espace publicitaire · 300×250